Next Generation Sequencing NGS Market By Workflow Analysis (NGS Pre-Sequencing, NGS Data Analysis, NGS Sequencing); By Application Analysis (HLA Testing, Oncology, Prenatal Testing, Idiopathic Diseases, Infectious Diseases); By End User Analysis (Academic Research, Hospitals & Clinics, Clinical Research, Pharma & Biotech Entities); By Technology Analysis (Whole genome sequencing, Whole exome sequencing, Targeted sequencing and resequencing) and By Regional Analysis – Global Forecast by 2023-2028
The Global Next Generation Sequencing NGS Market is expected to be around US$ 32.5 Billion by 2028 and will grow at a CAGR of more than 20% in the given forecast period.
COVID-19 Impact Analysis Report
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
20
REPORT DESCRIPTION
Next generation sequencing is a method of DNA sequencing to determine the appropriate order of nucleotides within a DNA molecule. Next generation sequencing technology enables speedy sequencing and produces million of DNA and RNA series with using next technology sequencer. Next generation sequencing (NGS) is likewise called high-throughput sequencing. NGS has range of different new sequencing technologies inclusive of illumina sequencing and roche 454 sequencing. NGS affords a low price and high throughput opportunity for sequencing DNA as compare to conventional Sanger sequencing. NGS provides its offerings in the studies subject such as metagenomics, cancers research, genetic ailment research and newborn sequencing. Numerous NGS systems provide low cost and excessive throughput sequencing such as illuminamiseq, lifestyles technologies ion proton and individual genome machine.
How Big is the Global Next Generation Sequencing NGS Market?
The Global Next Generation Sequencing NGS Market is expected to be around US$ 32.5 Billion by 2028 and will grow at a CAGR of more than 20% in the given forecast period.
The major driving factors of Global Next Generation Sequencing NGS Market are as follows:
• Falling price for genetic sequencing
• Increasing related progress of personalized medicine
• Rising prevalence of cancer
• Increase competition among prominent market entities
The restraining factors of Global Next Generation Sequencing NGS Market are as follows:
• Nonvalue based NGS reimbursement strategy
The Global Next Generation Sequencing NGS Market is segmented on the lines of its workflow, application, end user, technology and regional. Based on workflow segmentation it covers NGS pre sequencing, NGS data analysis and NGS sequencing. Under application segmentation it covers HLA testing, oncology, prenatal testing, idiopathic diseases and infectious diseases. Based on end user segmentation it covers academic research, hospitals & clinics, clinical research, pharma & biotech entities and other users. Technology is classified into whole genome sequencing, whole exome sequencing, targeted sequencing and resequencing. The Global Next Generation Sequencing NGS Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Next Generation Sequencing NGS and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Next Generation Sequencing NGS Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Global Next Generation Sequencing NGS Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Pacific Biosciences, Beijing Genomics Institute, Illumina Inc., 454 Life Sciences Corp. (Roche Holding Ag), GATC Biotech Ag., Life Technologies (Thermo Fisher Scientific), Oxford Nanopore Technologies Inc., Agilent Technologies Inc., Biomatters Ltd., Dnastar Inc., Macrogen Inc., HelicosBioSciences, Clc Bio (Qiagen), and Knome Inc. Company profile includes assign such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Next Generation Sequencing NGS Market has been segmented as below:
By Workflow Analysis
• NGS Pre-Sequencing
• NGS Data Analysis
• NGS Sequencing
By Application Analysis
• HLA Testing
• Oncology
• Prenatal Testing
• Idiopathic Diseases
• Infectious Diseases
By End User Analysis
• Academic Research
• Hospitals & Clinics
• Clinical Research
• Pharma & Biotech Entities
• Other users
By Technology Analysis
• Whole genome sequencing
• Whole exome sequencing
• Targeted sequencing and resequencing
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Next Generation Sequencing NGS Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Next Generation Sequencing NGS Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Methodology Steps
2.2 Research Design
2.3 Secondary and Primary Research Methodology
2.3.1 Secondary Research
2.3.1.1 Key Data From Secondary Sources
2.3.2 Primary Data
2.3.2.1 Breakdown of Primaries
2.3.2.2 Key Data From Primary Sources
2.3.2.3 Key Industry Insights
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary
3.1 Introduction
4 Premium Insights
4.1 Next-Generation Sequencing (NGS): Market Overview
4.2 NGS Market, By Product & Service (2019 vs 2025)
4.3 NGS Market Size, By Application, 2019 vs 2025
4.4 NGS Market, By End User (2019 vs 2025)
4.5 Geographic Analysis: NGS Market Size, By Product & Service (2019 vs 2025), USD Million
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Technological Advancements in Sequencing Platforms
5.2.1.2 Increasing Applications of NGS
5.2.1.3 Growing Number of Partnerships and Collaborations
5.2.1.4 Increasing Adoption of NGS Technologies Among Research Laboratories and Academic Institutes
5.2.1.5 Conferences and Workshops Increasing Awareness on NGS Products and Services
5.2.2 Restraints
5.2.2.1 Dearth of Skilled Professionals
5.2.2.2 Difficulties in Storage of Sequencing Data
5.2.3 Opportunities
5.2.3.1 Government Initiatives in Population Sequencing
5.2.3.2 Application of NGS in Precision Medicine & Biomarker Discovery
5.2.3.3 Emerging Markets Offer Significant Growth Opportunities
5.2.3.4 Cloud Computing, A Prospective Service
5.2.4 Challenges
5.2.4.1 Interpretation of Complex Data From NGS Platforms
5.2.4.2 Accuracy & Standardization Concerns in Diagnostic Testing
5.2.4.3 Issues Related to the Security of NGS Data
5.2.5 Industry Trends
5.2.5.1 Integration of Next-Generation Sequencing With Cloud-Based Technology
5.2.5.2 Focus on Cancer Research
5.2.5.3 Mergers and Acquisitions
5.2.5.4 Entry of New Market Players
6 Next-Generation Sequencing Market, By Product & Service
6.1 Introduction
6.2 Pre-Sequencing Products & Services Market
6.2.1 Sample Preparation
6.2.1.1 Dna Fragmentation, End Repair, A-Tailing, and Size Selection
6.2.1.2 Library Preparation & Target Enrichment
6.2.1.3 Quality Control
6.3 NGS Platforms, Consumables, & Services for Platforms
6.3.1 NGS Platforms Market
6.3.1.1 Illumina
6.3.1.1.1 Hiseq Series
6.3.1.1.2 Hiseq X Ten & Hiseq X Five
6.3.1.1.3 Miseq Series
6.3.1.1.4 Nextseq 500
6.3.1.1.5 Miniseq
6.3.1.2 Thermo Fisher Scientific (Life Technologies)
6.3.1.2.1 ION PGM
6.3.1.2.2 ION Proton
6.3.1.2.3 ION S5 & S5 XL
6.3.1.3 Pacific Biosciences
6.3.1.3.1 Pacbio Rs II
6.3.1.3.2 Sequel System
6.3.1.4 Oxford Nanopore
6.3.1.5 Other Next-Generation Sequencing Platforms
6.3.1.6 Recently Launched Sequencing Platforms
6.4 Sequencing Services Market
6.4.1 Targeted Re-Sequencing
6.4.2 Rna-Seq
6.4.3 De Novo Sequencing
6.4.4 Exome Sequencing
6.4.5 Chip-Seq
6.4.6 Whole-Genome Sequencing
6.4.7 Methyl-Seq
6.4.8 Other Applications
6.5 NGS Data Analysis, Storage, and Management (Bioinformatics)
6.5.1 NGS Data Analysis Software & Workbenches
6.5.2 NGS Data Analysis Services
6.5.3 NGS Storage, Management, and Cloud Computing Solutions
7 Next-Generation Sequencing Market, By Technology
7.1 Introduction
7.2 Sequencing By Synthesis
7.3 ION Semiconductor Sequencing
7.4 Single-Molecule Real-Time Sequencing
7.5 Nanopore Sequencing
8 Next-Generation Sequencing Market, By Application
8.1 Introduction
8.2 Diagnostics
8.3 Drug Discovery
8.4 Biomarker Discovery
8.5 Precision Medicine
8.6 Agriculture & Animal Research
8.7 Other Applications
9 Next-Generation Sequencing Market, By End User
9.1 Introduction
9.2 Research Centers and Academic & Government Institutes
9.3 Hospitals & Clinics
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users
10 Next-Generation Sequencing Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Favorable Government Funding Scenario in the U.S. Market
10.2.1.2 Growing Focus of NGS Market Players on Strengthening Their Presence in the U.S.
10.2.1.3 Increasing Number of NGS Conferences in the U.S.
10.2.2 Canada
10.2.2.1 Favorable Government Funding Scenario in Canada
10.2.2.2 Growing Focus of Market Players on Expanding Their Presence in Canada
10.3 Europe
10.3.1 Market Players Capitalizing on Opportunities in the European NGS Market
10.3.1.1 Launch of New and Advanced Products and Services
10.3.1.2 Partnerships/Agreements/Collaborations
10.3.2 Germany, U.K., and Belgium: Major Hubs for Scientific Research
10.3.3 Growing Funding and Investments for NGS in Europe
10.4 Asia-Pacific
10.4.1 Growing Focus of Domestic and Multinational Players on APAC Market
10.4.1.1 Launch of Advanced NGS Products and Services
10.4.1.2 Partnerships/Collaborations/Agreements to Co-Develop Advanced NGS Products and Services
10.4.2 Favorable Government Funding Scenario
10.4.3 Conferences/Seminars/Training Programs
10.5 Rest of the World (RoW)
10.5.1 Focus of Key Market Players on Expanding Their Presence in RoW Countries
10.5.2 Workshops and Conferences
10.5.3 Favorable Initiatives By Public and Private Organizations
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Product Launches, Product Enhancements, and Service Launches
11.3.2 Agreements, Partnerships, Collaborations, and Contracts
11.3.3 Mergers and Acquisitions
11.3.4 Expansions
11.3.5 Other Developments
The Global Next Generation Sequencing NGS Market has been segmented as below:
By Workflow Analysis
• NGS Pre-Sequencing
• NGS Data Analysis
• NGS Sequencing
By Application Analysis
• HLA Testing
• Oncology
• Prenatal Testing
• Idiopathic Diseases
• Infectious Diseases
By End User Analysis
• Academic Research
• Hospitals & Clinics
• Clinical Research
• Pharma & Biotech Entities
• Other users
By Technology Analysis
• Whole genome sequencing
• Whole exome sequencing
• Targeted sequencing and resequencing
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
Got a question? We've got answers. If you have some other questions, see our support center.
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE